Session Information

  • WCLC 2022

    2022 World Conference on Lung Cancer

    Conference Program for 2022 the World Conference on Lung Cancer

    Presentation Date(s):  
    • August 6 - 9, 2022
    • Total Presentations: 2137

    All times listed are in Vienna, Austria Time, CEST (UTC+2:00)

    PL - Plenary
    IBS - Interactive Breakfast Session (in-person attendees only)
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    P - Posters
    EP - ePosters
    WS - Workshops
    LA – Lectureship Awards
    IS - Industry Symposium

Filter Results:

Show Only CME Accredited Sessions

  • +

    MA01 - Molecular Subtypes and Prognostic Factors for SCLC and Neuroendocrine Tumors

    • 10:45 - 11:45
    • 8/07/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Mini Oral
    • Track: Small Cell Lung Cancer and Neuro-Endocrine Tumors
    • +

      Session Moderator

      10:45 - 10:46  |  Presenter: Fabio Pagni

      • Abstract

      Loading...

    • +

      Session Moderator

      10:45 - 10:46  |  Presenter: Ferdinandos Skoulidis

      • Abstract

      Loading...

    • +

      MA01.01 - Session Introduction

      10:45 - 10:46  |  Presenter: Fabio Pagni

      • Abstract

      Loading...

    • +

      MA01.02 - Session Introduction

      10:46 - 10:47  |  Presenter: Ferdinandos Skoulidis

      • Abstract

      Loading...

    • +

      MA01.03 - Exploiting DNA Methylation for Classification of SCLC Subtypes from Liquid Biopsies Using a Robust Machine Learning Approach

      10:47 - 10:52  |  Presenter: Simon Heeke

      • Abstract

      Loading...

    • +

      MA01.04 - Molecular Subtypes of Surgically Resected Small Cell Lung Cancer: Expression Pattern and Prognostic Relevance

      10:52 - 10:57  |  Presenter: Zsolt Megyesfalvi

      • Abstract

      Loading...

    • +

      MA01.05 - Immuno-microenvironment (TIME) Heterogeneity of Small Cell Lung Cancer (SCLC) Stratified by Molecular Subtypes

      10:57 - 11:02  |  Presenter: Jiyan DONG

      • Abstract

      Loading...

    • +

      MA01.06 - Discussant

      11:02 - 11:12  |  Presenter: Kenneth John O'Byrne

      • Abstract

      Loading...

    • +

      MA01.07 - From Molecular to Histological Characterization of Lung Carcinoids via Computer Vision and Spatial Genomics

      11:12 - 11:17  |  Presenter: émilie Mathian

      • Abstract

      Loading...

    • +

      MA01.08 - Impact of [18F]FDG PET/CT-derived Metabolic Parameters on Outcomes in Extensive-stage SCLC

      11:17 - 11:22  |  Presenter: Giuseppe Lamberti

      • Abstract

      Loading...

    • +

      MA01.09 - Characterising Aggressive Pulmonary Carcinoids Through Integrative Omics Analysis Within the lungNENomics Project

      11:22 - 11:27  |  Presenter: Alexandra Sexton-Oates

      • Abstract

      Loading...

    • +

      MA01.10 - Discussant

      11:27 - 11:37  |  Presenter: Michael Boyer

      • Abstract

      Loading...

    • +

      MA01.11 - Live Q&A

      11:37 - 11:45

      • Abstract

      Loading...

  • +

    OA03 - Molecular Targeted Treatments

    • 14:30 - 15:40
    • 8/07/2022
    • Location: Hall C7
    • Not for CME Credit
    • Type: Oral
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • +

      OA03.06 - CodeBreaK 100/101: First Report of Safety/Efficacy of Sotorasib in Combination with Pembrolizumab or Atezolizumab in Advanced KRAS p.G12C NSCLC

      15:02 - 15:12  |  Presenter: Bob T. Li

      • Abstract

      Loading...

  • +

    EP08.02 - Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments

    • 09:45 - 18:00
    • 8/07/2022
    • Location: Exhibit Hall - Hall B
    • Not for CME Credit
    • Type: E-Poster
    • Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
    • +

      EP08.02-163 - Real-World Case Series on Efficacy and Safety of Amivantamab for EGFR-mutant Non-small Cell Lung Cancer

      Presenter: Xiuning Le

      • Abstract

      Loading...